Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Gilead Sciences, Inc. GILD

Healthcare  —  Drug Manufacturers General
150.93 1.24 0.83% as of 25 Sep
Market cap
$183.2B
P/E
0.0×
S&P 500 Member Dividend Champion (10y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Gilead Sciences, Inc. (GILD) Book value per share

Gilead Sciences, Inc.'s book value per share at the end of fiscal 2025 was 18.2×, up 17.8% from 15.4× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 9.4×. Over the past ten years it has ranged from 13.1× (fiscal 2015) to 18.2× (fiscal 2023); the current reading is higher than 91% of that period. Gilead Sciences, Inc. ranks 13th of 21 Drug Manufacturers General companies by book value per share.

Book value per share, annual

Annual

Period Book value per share Change
FY2025 18.2× 17.80%
FY2024 15.4× (15.33%)
FY2023 18.2× 7.86%
FY2022 16.9× 0.77%
FY2021 16.8× 15.70%
FY2020 14.5× (18.72%)
FY2019 17.8× 7.50%
FY2018 16.6× 5.77%
FY2017 15.7× 8.47%
FY2016 14.5× 10.77%

Quarterly

Period Book value per share Change
Jun 2026 9.4× (49.92%)
Mar 2026 18.9× 3.76%
Dec 2025 18.2× 5.33%
Sep 2025 17.3× 9.70%
42 more quarters

Against its own ten years

Low 13.1× High 18.2×
Ten-year median 16.6×
Current reading's percentile 91

Book value per share against peers

Company Book value per share
SNY Sanofi compare 33.8×
AZN AstraZeneca PLC compare 32.5×
NVS Novartis AG compare 22.0×
AMGN Amgen Inc. compare 21.6×
PFE Pfizer Inc. compare 15.0×
GSK GSK PLC Sponsored ADR compare 11.5×
BMY Bristol Myers Squibb Company compare 10.9×
GILD Gilead Sciences, Inc. 9.4×
NVO Novo Nordisk A/S compare 7.8×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on GILD